Home Control Partners with NTU Singapore to Bolster Core Technology and R&D Collaboration
Home Control International Limited (1747.HK), a Hong Kong-listed company, has recently announced a significant partnership with Nanyang Technological University (NTU Singapore) aimed at enhancing core technology and research and development (R&D) within the AIoT home healthcare sector. This collaboration is poised to accelerate the deployment of AI-driven solutions in healthcare, a market with immense commercial potential.
Strategic Memorandum of Understanding (MoU)
The partnership is formalized through a Strategic Memorandum of Understanding (MoU), focusing on the exploration of AIoT-enabled healthcare solutions. Key areas of collaboration include:
- Development of a personal healthcare platform.
- Ensuring data security and maintenance within the healthcare management system.
Notably, Home Control’s subsidiary, Orbiva Limited, has signed an Intellectual Property (IP) Licensing Agreement with NTUitive Pte Ltd, NTU’s innovation and enterprise arm, to support applications in home care, healthcare, IoT, and AIoT.
Focus on Healthcare as a Strategic Direction
In its 2025 interim report, Home Control identified healthcare as a key strategic direction, supported by new funding obtained through share placements. This funding aims to enhance hardware infrastructure and core software R&D, with expectations of tangible business results over the coming year.
Data Security and Trustworthy AI
On January 22, 2026, the Singapore government released a new Model AI Governance Framework for Agentic AI, emphasizing the importance of data security. This framework addresses public concerns across four dimensions:
- Risk assessment
- Accountability
- Technical control
- User awareness
This collaboration aligns with the framework’s goals, helping to establish a reliable technical foundation for product development and commercialization in healthcare.
Collaborating with NTU Singapore
NTU Singapore is globally recognized for its expertise in AI, cybersecurity, data science, and medical technology. The university’s research is supported by the Singapore government, ensuring its relevance and potential for commercialization.
NTU has previously collaborated with organizations like Alibaba’s DAMO Academy, promoting AI applications in various sectors, including households and healthcare facilities. This demonstrates NTU’s capabilities in transforming high-quality research into practical applications.
AI Healthcare Acceleration Phase
The AI healthcare sector is transitioning from conceptual frameworks to large-scale commercialization. Major players like NVIDIA are advancing “full-stack” AI strategies, and numerous firms are integrating AI into healthcare diagnostics and management. Home Control’s focus on AIoT home healthcare is expected to synergize with its existing smart control technologies.
Stable Fundamentals and Growth Expectations
Home Control’s core business remains robust, with a resumption of dividend payments signaling strong cash flow. The recent share placement injects new capital to expedite business development. As R&D efforts mature, the first half of 2026 is anticipated to be crucial for evaluating the company’s strategic transformation.
Overall, the structural growth of AI-driven healthcare, combined with Home Control’s clear roadmap, positions the company favorably for mid-to-long-term growth in the home healthcare sector.
–End–
